| Title | ASCO Abstract and Poster |
|---|---|
| Description | The combination of IN10018 with PLD showed promising antitumor activities and manageable safety profile in PROC patients. This combination warrants further confirmation in a randomized controlled trial. |
| Organism | Homo sapiens |
| Data Type | Clinical Research data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA012948 |
| Release Date | 2026-01-30 |
| Submitter | Shu Fang (shu.fang@inxmed.com) |
| Organization | InxMed Co., Ltd |
| Submission Date | 2022-11-02 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX002262-03 | ASCO Poster updated | 1 | Clinical Research data | 330.1 KB | xlsx | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|